drugset / Trial / NCT06300398
IAMA-6 Oral Dose Study in Healthy Adults
RandomizedFactorialDouble-blindOther
Summary
The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of IAMA-6 administered orally to healthy adults.
Timeline
- Start
- 2024-01-08
- Primary completion
- 2024-10-10
- Completion
- 2024-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IAMA-6 | Unknown | — | Oral |